These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32295862)

  • 1. Compendial Methods: Suitability Verification, Challenges and Recommendations for Proteins.
    Chung WL; Yin J; Messick S; Saggu M; Tschudi K; Woys A; Rahimi R; Azarias M; Kong C; Kabakoff B
    PDA J Pharm Sci Technol; 2020; 74(5):581-591. PubMed ID: 32295862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Spectral Method for Quantitative Measurement of Color in Protein Drug Solutions.
    Yin J; Swartz TE; Zhang J; Patapoff TW; Chen B; Marhoul J; Shih N; Kabakoff B; Rahimi K
    PDA J Pharm Sci Technol; 2016; 70(4):382-91. PubMed ID: 27091890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding opalescence measurements of biologics - A comparison study of methods, standards, and molecules.
    Kunz P; Stuckenberger E; Hausmann K; Gentiluomo L; Neustrup M; Michalakis S; Rieser R; Romeijn S; Wichmann C; Windisch R; Hawe A; Jiskoot W; Menzen T
    Int J Pharm; 2022 Nov; 628():122321. PubMed ID: 36273703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Spectral Method for Color Quantitation of a Protein Drug Solution.
    Swartz TE; Yin J; Patapoff TW; Horst T; Skieresz SM; Leggett G; Morgan CJ; Rahimi K; Marhoul J; Kabakoff B
    PDA J Pharm Sci Technol; 2016; 70(4):361-81. PubMed ID: 27091888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Risk- and Science-Based Approach to the Acceptance Sampling Plan Inspection of Protein Parenteral Products.
    Spasoff A; Bennis A; Atkinson S; Elliott C; Freund E; Narhi L
    J Pharm Sci; 2018 Sep; 107(9):2306-2309. PubMed ID: 29859961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products.
    Parveen S; Kaur S; David SA; Kenney JL; McCormick WM; Gupta RK
    Vaccine; 2011 Oct; 29(45):8012-23. PubMed ID: 21871516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimerization Dictates Solution Opalescence of a Monoclonal Antibody.
    Yang TC; Langford AJ; Kumar S; Ruesch JC; Wang W
    J Pharm Sci; 2016 Aug; 105(8):2328-37. PubMed ID: 27373839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical review of analytical methods for subvisible and visible particles.
    Narhi LO; Jiang Y; Cao S; Benedek K; Shnek D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):373-81. PubMed ID: 19519412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method evaluation: automated microscopy as a compendial test for particulates in parenteral solutions.
    Barber TA; Lannis MD; Williams JG
    J Parenter Sci Technol; 1989; 43(1):27-47. PubMed ID: 2926604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opalescence Arising from Network Assembly in Antibody Solution.
    Nakauchi Y; Nishinami S; Murakami Y; Ogura T; Kano H; Shiraki K
    Mol Pharm; 2022 Apr; 19(4):1160-1167. PubMed ID: 35274955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 May; 13(5):1431-44. PubMed ID: 27017836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opalescence Measurements: Improvements in Fundamental Knowledge, Identifying Sources of Analytical Biases, and Advanced Applications for the Development of Therapeutic Proteins.
    Barros M; Zhang X; Kenrick S; Valente JJ
    J Pharm Sci; 2021 Nov; 110(11):3550-3557. PubMed ID: 34111445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
    Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS
    J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opalescence in monoclonal antibody solutions and its correlation with intermolecular interactions in dilute and concentrated solutions.
    Raut AS; Kalonia DS
    J Pharm Sci; 2015 Apr; 104(4):1263-74. PubMed ID: 25556561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modernization of Physical Appearance and Solution Color Tests Using Quantitative Tristimulus Colorimetry: Advantages, Harmonization, and Validation Strategies.
    Pack BW; Montgomery LL; Hetrick EM
    J Pharm Sci; 2015 Oct; 104(10):3299-313. PubMed ID: 26173406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-visible particle quantitation in protein therapeutics.
    Cao S; Jiao N; Jiang Y; Mire-Sluis A; Narhi LO
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):73-9. PubMed ID: 20144454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of USP antibody standard for system suitability in capillary electrophoresis sodium dodecyl sulfate (CE-SDS) for release and stability methods.
    Esterman AL; Katiyar A; Krishnamurthy G
    J Pharm Biomed Anal; 2016 Sep; 128():447-454. PubMed ID: 27344634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifecycle management in pharmaceutical analysis: How to establish an efficient and relevant continued performance monitoring program.
    Ermer J; Aguiar D; Boden A; Ding B; Obeng D; Rose M; Vokrot J
    J Pharm Biomed Anal; 2020 Mar; 181():113051. PubMed ID: 31962246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.